13 Total results for product and free and sample content found
Medtech Insight
By Reed Miller 08 Dec 2020
The $800m sale of BTG Specialty Pharmaceuticals business to SERB leaves Boston Scientific with BTG’s successful interventional oncology and vascular products.
Topic M A Market Intelligence
Scrip
27 Nov 2020
Scrip has been scrutinizing significant M&A deals in the pharma industry in light of companies’ 2019 financial results. We bring you insights into the impact of major acquisitions and divestments by Big Pharma, and consider what it means for the future.
Topic M A
Scrip
By Andrew McConaghie 27 Nov 2020
John Thero insists company is focused on approval and launch, as interest in European rights grow.
Topic Cardiovascular M A
Biomedtracker
27 Nov 2020
In preparation for the webinar, download your free infographic, a snapshot view of M&A’s biggest deals and major players and what their activities indicate for the year ahead.
Topic M A
Biomedtracker
By Daniel Chancellor 27 Nov 2020
Using M&A activity as a barometer for the overall health of the biopharma industry, we explore biopharma’s biggest deals of the past decade and examine what they may presage for the year to come. Dive into key insights on trends, M&A drivers, companies to watch, and more.
Topic M A
Scrip
By Ian Haydock 17 Nov 2020
Take a brief audio tour around the main biopharma industry events of the past week, as brought to you by Scrip's global team, in this podcast version of Five Must-Know Things.
Topic Coronavirus M A
Pink Sheet
By Brenda Sandburg 17 Nov 2020
Commissioners vote 3-2 that Mylan and Pfizer’s Upjohn can combine after divesting seven products; dissenting votes focus on price fixing allegations as commissioners Chopra and Slaughter criticize majority for not addressing government’s case against Pfizer and Mylan. Former FTC attorneys note that if Biden wins the presidential election, he could nominate one of the dissenters to FTC chair and give more traction to their views.
Topic US Election 2020 M A Legal Issues
Scrip
By Ian Haydock 28 Aug 2020
Join us for a quick audio roundup of five useful things to know from Scrip's recent coverage of the global biopharmaceutical sector.
Topic Coronavirus M A
In Vivo
15 Apr 2020
Gain a view into the market gaps, opportunities, and trends in biopharma with a look at deal-making from In Vivo. Examine how deal-making has impacted the industry and shifted market dynamics and learn how you can use knowledge of these trends to inform your own strategies.
No Records Found
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: